Parkinson's Disease
Parkinson's disease (PD) is a degenerative disorder of the central nervous system that often impairs the sufferer's motor skills and speech. Parkinson's disease belongs to a group of conditions called movement disorders. It is characterized by muscle rigidity, tremor, a slowing of physical movement, and in extreme cases, a loss of physical movement. The primary symptoms are the results of excessive muscle contraction, normally caused by the insufficient formation and action of dopamine, which is produced in the dopaminergic neurons of the brain. Secondary symptoms may include high level cognitive dysfunction and subtle language problems. PD is both chronic and progressive.
PD is the most common cause of parkinsonism, a group of similar symptoms. PD is also called "primary parkinsonism" or "idiopathic PD" ("idiopathic" meaning of no known cause). While most forms of parkinsonism are idiopathic, there are some cases where the symptoms may result from toxicity, drugs, genetic mutation, head trauma, or other medical disorders.
Parkinson disease affects movement. Typical other symptoms include disorders of mood, behavior, thinking, and sensation. Individual patients' symptoms may be quite dissimilar; progression is also distinctly individual.
Parkinson's disease is a chronic disorder that requires broad-based management including patient and family education, support group services, general wellness maintenance, exercise, and nutrition. At present, there is no cure for PD, but medications or surgery can provide relief from the symptoms.
...More at Wikipedia
Related Links:
Parkinson's Disease
Questions recently asked by other users
Latest Parkinson's Disease News From Medical News Today.
- Curry Spice Curcumin And Parkinson's Disease? Protects Against A53T Alpha-synuclein-induced Toxicity
- Mayo Clinic Develops Potential New Therapy To Stop The Progression Of Parkinson's Disease
- Alzheimer's, Parkinson's Diseases Could Be Halted By Protecting Neurons
- A Window Into Parkinson's Disease
- £2 Million Clinical Trials Funding For Alzheimer's And Parkinson's Research
- UK Experts Warn About Untested Remedies And Issue Guide To Consumers
- Alnylam And Collaborators Publish New Pre-Clinical Research On Therapeutic Silencing Of Key Gene Implicated In Parkinson's Disease
- Treatment For Gout And The Condition's Protective Effects
- 3-Substituted Indolones As Novel Therapeutic Compounds For Neurodegenerative Conditions
- Two New Dosage Strengths Of Stalevo(R) Approved In The U.S. Provide Greater Dosing Flexibility For People With Parkinson's Disease
- New Project Will Study Promising 'Personalized' Treatment For Parkinson's
